| Response to the novel corona virus (COVID-19) pandemic across Africa: successes, challenges, and implications for the future OO Ogunleye, D Basu, D Mueller, J Sneddon, RA Seaton, ... Frontiers in pharmacology 11, 1205, 2020 | 207 | 2020 |
| Strategies to improve antimicrobial utilization with a special focus on developing countries B Godman, A Egwuenu, M Haque, OO Malande, N Schellack, S Kumar, ... Life 11 (6), 528, 2021 | 156 | 2021 |
| Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries … B Godman, M Haque, J McKimm, M Abu Bakar, J Sneddon, J Wale, ... Current medical research and opinion 36 (2), 301-327, 2020 | 154 | 2020 |
| Review of ongoing activities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future B Godman, D Basu, Y Pillay, JC Mwita, GM Rwegerera, ... Frontiers in pharmacology 11, 108, 2020 | 120 | 2020 |
| Rapid assessment of price instability and paucity of medicines and protection for COVID-19 across Asia: findings and public health implications for the future B Godman, M Haque, S Islam, S Iqbal, UL Urmi, ZM Kamal, SA Shuvo, ... Frontiers in public health 8, 585832, 2020 | 100 | 2020 |
| Availability and price changes of potential medicines and equipment for the prevention and treatment of COVID-19 among pharmacy and drug stores in Bangladesh; findings and … M Haque, S Islam, S Iqbal, UL Urmi, ZM Kamal, SA Shuvo, A Rahman, ... Bangladesh Journal of Medical Science 19, S36-S50, 2020 | 82 | 2020 |
| Fixed dose drug combinations–are they pharmacoeconomically sound? Findings and implications especially for lower-and middle-income countries B Godman, H McCabe, T D Leong, D Mueller, AP Martin, I Hoxha, ... Expert review of pharmacoeconomics & outcomes research 20 (1), 1-26, 2020 | 81 | 2020 |
| Antimicrobial point prevalence surveys in two Ghanaian hospitals: opportunities for antimicrobial stewardship DK Afriyie, IA Sefah, J Sneddon, W Malcolm, R McKinney, L Cooper, ... JAC-Antimicrobial Resistance 2 (1), dlaa001, 2020 | 79 | 2020 |
| Rapid assessment of the potential paucity and price increases for suggested medicines and protection equipment for COVID-19 across developing countries with a particular focus … IA Sefah, OO Ogunleye, DO Essah, SA Opanga, N Butt, A Wamaitha, ... Frontiers in pharmacology 11, 588106, 2021 | 70 | 2021 |
| Tackling antimicrobial resistance across sub-Saharan Africa: Current challenges and implications for the future B Godman, A Egwuenu, E Wesangula, N Schellack, AC Kalungia, ... Expert Opinion on Drug Safety 21 (8), 1089-1111, 2022 | 56 | 2022 |
| Challenges and innovations brought about by the COVID-19 pandemic regarding medical and pharmacy education especially in Africa and implications for the future A Etando, AA Amu, M Haque, N Schellack, A Kurdi, AA Alrasheedy, ... Healthcare 9 (12), 1722, 2021 | 53 | 2021 |
| Antibiotic prescribing patterns in Ghana, Uganda, Zambia and Tanzania hospitals: results from the global point prevalence survey (G-PPS) on antimicrobial use and stewardship … N D’Arcy, D Ashiru-Oredope, O Olaoye, D Afriyie, Z Akello, D Ankrah, ... Antibiotics 10 (9), 1122, 2021 | 53 | 2021 |
| Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income … B Godman, C Grobler, M Van-De-Lisle, J Wale, WB Barbosa, A Massele, ... Expert opinion on pharmacotherapy 20 (18), 2237-2255, 2019 | 50 | 2019 |
| Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future B Godman, D Basu, Y Pillay, PHRF Almeida, JC Mwita, GM Rwegerera, ... Hospital practice 48 (2), 51-67, 2020 | 49 | 2020 |
| Availability of medicines in community pharmacy to manage patients with COVID-19 in Kenya; pilot study and implications SA Opanga, N Rizvi, A Wamaitha, IA Sefah, B Godman Scholars Academic Journal of Pharmacy 10 (3), 36-43, 2021 | 46 | 2021 |
| Supporting global antimicrobial stewardship: antibiotic prophylaxis for the prevention of surgical site infection in low-and middle-income countries (LMICs): a scoping review … L Cooper, J Sneddon, DK Afriyie, IA Sefah, A Kurdi, B Godman, ... JAC-Antimicrobial Resistance 2 (3), dlaa070, 2020 | 41 | 2020 |
| Activities in Namibia to limit the prevalence and mortality from COVID-19 including community pharmacy activities and the implications D Kibuule, L Nambahu, I Sefah, A Kurdi, T Phuong, HY Kwon, B Godman Scholars Academic Journal of Pharmacy 10 (5), 2021 | 39 | 2021 |
| Coronavirus disease 2019 (COVID-19) pandemic across Africa: current status of vaccinations and implications for the future OO Ogunleye, B Godman, JO Fadare, S Mudenda, AO Adeoti, ... Vaccines 10 (9), 1553, 2022 | 38 | 2022 |
| The current situation regarding long-acting insulin analogues including biosimilars among African, Asian, European, and South American countries; findings and implications for … B Godman, M Haque, T Leong, E Allocati, S Kumar, S Islam, J Charan, ... Frontiers in public health 9, 671961, 2021 | 37 | 2021 |
| Utilisation, availability and price changes of medicines and protection equipment for COVID-19 among selected regions in India: findings and implications M Haque, S Kumar, J Charan, R Bhatt, S Islam, S Dutta, JP Abhayanand, ... Frontiers in pharmacology 11, 582154, 2021 | 36 | 2021 |
Brian GodmanKarolinska Institute, Strathclyde Institute of Pharmacy and Biomedical SciencesVerified email at briangodman.co.uk
